O. Ringdén

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT

H. Einsele, C. Meisner, T. Klingebiel, 2009, Bone Marrow Transplantation.

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial.

H. Prentice, F. Meunier, O. Ringdén, 1991, The Journal of antimicrobial chemotherapy.

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients.

P. Fenaux, N. Gorin, S. Tura, 1991, The Journal of antimicrobial chemotherapy.

Disturbances in the oral cavity in pediatric long-term survivors after different forms of antineoplastic therapy.

O. Ringdén, O. Björk, S. Söderhäll, 1994, Pediatric dentistry.

PCR-Based Liposomal Amphotericin B Treatment Following Allogeneic Stem Cell Transplantation Is a Safe Treatment Strategy: Preliminary Results of a Prospective Study.

H. Einsele, C. Meisner, L. Kanz, 2004 .

Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT

P. Ljungman, O. Ringdén, J. Aschan, 2007, Bone Marrow Transplantation.